Presently, IFN-ε is used for the treatment of viral infectious diseases, such as condyloma acuminatum, hepatitis B and C, and several tumors, including laryngeal multiple papilloma, bladder cancer, and cervical cancer, but these treatments are all in the preclinical research stage. Here, IFNE is linked to anogenital human papillomavirus infection.